or Try an Advanced Search...

    Toxicology Stocks List

    Symbol Grade Name % Change
    INM B InMed Pharmaceuticals Inc. 0.22
    BLFS C BioLife Solutions, Inc. 2.44
    CRL C Charles River Laboratories International, Inc. 0.81
    EXPO D Exponent, Inc. 2.26
    HBIO F Harvard Bioscience, Inc. 5.09
    NEOG F Neogen Corporation 2.74
    ATHE F Alterity Therapeutics Limited 0.00
    SAGE F Sage Therapeutics, Inc. 6.60
    EGRX F Eagle Pharmaceuticals, Inc. 18.75
    OSUR F OraSure Technologies, Inc. 0.78
    View As Page of Charts
    Related Industries: Biotechnology Business Services Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Pharmaceutical Biology Medicine Pharmacology Toxicology Testing Cell Biology Chemical Diagnostic Products Drug Discovery Food Safety Genetic Testing Immunoassay Life Sciences Neuroscience Organs Pathology Regenerative Medicine Acid Adenosine

    Related ETFs - A few ETFs which own one or more of the above listed Toxicology stocks.

    Symbol Grade Name Weight
    PSIL C AdvisorShares Psychedelics ETF 4.78
    AWEG A Alger Weatherbie Enduring Growth ETF 3.62
    IVEG B iShares Emergent Food and AgTech Multisector ETF 2.59
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 2.47
    XHE B SPDR S&P Health Care Equipment 2.1
    View all Toxicology ETFs...
    Compare ETFs
    Compare AWEG to IVEG Compare AWEG to XHE Compare PSIL to XHE

        Toxicology Stocks Recent News

        Date Stock Title
        Nov 22 SAGE Sage Therapeutics price target lowered to $4 from $7 at BofA
        Nov 21 SAGE Sage Therapeutics Drug's Failure in Huntington's 'Not Surprising,' RBC Says
        Nov 21 SAGE Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
        Nov 21 SAGE Sage ends dalzanemdor development following Phase II trial failure
        Nov 21 SAGE SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study
        Nov 21 SAGE Sage raised to sector perform by RBC in wake of drug failure
        Nov 20 SAGE After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
        Nov 20 SAGE Sage slips as Huntington’s Disease therapy fails in mid-stage trial
        Nov 20 SAGE Sage’s string of research failures continues
        Nov 20 SAGE Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
        Nov 19 SAGE CNS Drug Development: Same As It Ever Was
        Nov 19 CRL Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
        Nov 18 OSUR OraSure to Participate in Upcoming Investor Conference
        Related Industries: Biotechnology Business Services Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Biotechnology Pharmaceutical Biology Medicine Pharmacology Toxicology Testing Cell Biology Chemical Diagnostic Products Drug Discovery Food Safety Genetic Testing Immunoassay Life Sciences Neuroscience Organs Pathology Regenerative Medicine Acid Adenosine
        Toxicology

        Toxicology is a discipline, overlapping with biology, chemistry, pharmacology, and medicine, that involves the study of the adverse effects of chemical substances on living organisms and the practice of diagnosing and treating exposures to toxins and toxicants. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Factors that influence chemical toxicity include the dosage (and whether it is acute or chronic), route of exposure, species, age, sex, and environment. Toxicologists are experts on poisons and poisoning.

        More about Toxicology
        Browse All Tags